Posts by Mauricio A. Villavicencio-Theoduloz, MD
-
TCS–VAD Better Than ECMO for Acute Support Before Heart Transplantation
In a nationwide study, patients bridged to transplant with temporary circulatory support–ventricular assist devices had post-transplant survival superior to those bridged with extracorporeal membrane oxygenation and similar to those bridged with left-ventricular assist devices.
-
Multidisciplinary, Protocolized ECMO Team Substantially Improves In-Hospital Survival
Extracorporeal membrane oxygenation is a "team sport," researchers at Massachusetts General Hospital say. In the largest single-center review of ECMO outcomes to date, they found that implementing a protocolized, multidisciplinary approach significantly improved in-hospital survival.
-
Prior Sternotomy Linked to Worse Survival After Cardiac Transplantation
A history of sternotomy is a risk factor for worse survival after cardiac transplantation, cardiac surgeons at Massachusetts General Hospital determined after reviewing nationwide data.
-
Innovation Increases Availability of Hearts and Lungs for Transplant
Warm perfusion and careful selection of marginal organs allow Mass General transplant teams to save more lives.
-
ECMO Linked to Increased Survival Rate in High-Risk Pulmonary Embolism Patients
A Mass General team finds ECMO allows for more aggressive interventions to increase survival of high-risk pulmonary embolism patients.
Biography
Mauricio Villavicencio, MD, MBA, is cardiac surgeon at Massachusetts General Hospital. He is a member of the Mass General Corrigan Minehan Heart Center and Mass General Transplant Center, and is the Director of Lung Transplantation and ECMO in the Division of Cardiac Surgery.
Dr. Villavicencio earned his medical degree from Pontificia Universidad Catolica de Chile and then completed both general and cardiac surgical residencies in Santiago, Chile. He then pursued an advanced cardiovascular surgery fellowship at the Mayo Clinic, followed by cardiopulmonary transplantation fellowship at The Freeman Hospital, which is one of the premier thoracic transplant centers in Europe.
Dr. Villavicencio returned to the U.S. after a seven-year tenure in Chile, where he introduced the country to the use of ventricular assist devices as a regular therapeutic tool. He served as the founder and chief of the National Cardiopulmonary Transplantation Service. In 2015, Dr. Villavicencio undertook a thoracic transplantation and ventricular assist devices fellowship at Duke University Medical Center.
His practice includes the full spectrum of adult cardiac surgery, with an emphasis in valve and coronary surgery.